Late-onset visceral varicella-zoster virus infection presented as acute liver failure after allogeneic hematopoietic stem cell transplantation.
Taku KikuchiMari AraiYuya KodaJun KatoTakayuki ShimizuHarutaka KatanoYoko Fujii-NishimuraMichiie SakamotoHirotoshi EbinumaNobuhiro NakamotoTakanori KanaiShinichiro OkamotoTakehiko MoriPublished in: Transplant infectious disease : an official journal of the Transplantation Society (2019)
Although much less common than localized zoster, initial presentation of varicella-zoster virus (VZV) as visceral infection can occur especially after allogeneic hematopoietic stem cell transplantation (HSCT). We herein report a case of post-transplant visceral VZV infection presenting as fatal acute liver failure. It developed 4 years after allogeneic HSCT when a long-term prophylactic anti-VZV agent administration was discontinued. VZV should be listed as a causative pathogen of acute liver failure even years after allogeneic HSCT. Indication for, and duration of anti-VZV prophylaxis should be further investigated.
Keyphrases
- liver failure
- allogeneic hematopoietic stem cell transplantation
- hematopoietic stem cell
- hepatitis b virus
- late onset
- acute lymphoblastic leukemia
- acute myeloid leukemia
- stem cell transplantation
- insulin resistance
- bone marrow
- early onset
- type diabetes
- high dose
- low dose
- skeletal muscle
- mass spectrometry
- respiratory failure